Novaliq strengthens executive management team by appointing Christian Roesky (PHD, as chief executive officer)

Former B+L, Abbott and Alcon Executive To Lead Company Through Multiple Product Development, Clinical Trial, and Commercialization Programs Bernhard Günther, Co-founder of Novaliq, Named Chief Innovation Officer  Novaliq GmbH, a specialty pharmaceutical company with a disruptive drug delivery platform that transforms poorly soluble drugs into effective ocular therapeutics, today announced the appointment of Christian Roesky, PhD,…